These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26825166)

  • 1. Neutrophilic Dermatosis Limited to Lipo-Lymphedematous Skin in a Morbidly Obese Woman on Dasatinib Therapy.
    Ainechi S; Carlson JA
    Am J Dermatopathol; 2016 Feb; 38(2):e22-6. PubMed ID: 26825166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent and Fixed Neutrophilic Dermatosis Associated With Dasatinib.
    Bergman JC; Ly TY; Keating MM; Hull PR
    J Cutan Med Surg; 2018; 22(6):621-623. PubMed ID: 29754527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib].
    de Masson A; Bouvresse S; Clérici T; Mahé E; Saïag P
    Ann Dermatol Venereol; 2011 Feb; 138(2):135-9. PubMed ID: 21333826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sweet syndrome in a patient with chronic myelogenous leukemia under dasatinib treatment.
    Matsuda T; Ueda-Hayakawa I; Kambe N; Fujita S; Okamoto H
    J Dermatol; 2019 Sep; 46(9):e317-e318. PubMed ID: 30932238
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketoconazole-induced Sweet syndrome: a new association.
    Baquerizo Nole KL; Lee E; Villada G; Romanelli P
    Am J Dermatopathol; 2015 May; 37(5):419-22. PubMed ID: 25590289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature.
    Kieffer C; Cribier B; Lipsker D
    Medicine (Baltimore); 2009 Jan; 88(1):23-31. PubMed ID: 19352297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity-related neutrophilic dermatosis: a newly described entity that is not exclusive of systemic lupus erythematosus.
    Saeb-Lima M; Charli-Joseph Y; Rodríguez-Acosta ED; Domínguez-Cherit J
    Am J Dermatopathol; 2013 Aug; 35(6):655-60. PubMed ID: 23518639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous Sweet syndrome as a presentation of chronic myelogenous leukaemia.
    Abbas SW; Shah Z; Shaikh MU
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36455980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophilic urticarial dermatosis and Sweet-like neutrophilic dermatosis: under-recognized neutrophilic dermatoses in lupus erythematosus.
    Lee WJ; Kang HJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
    Lupus; 2018 Apr; 27(4):628-636. PubMed ID: 29058993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sweet syndrome-like neutrophilic infiltrate as initial presentation of acute myelogenous leukemia.
    Travassos AR; Soares-de-Almeida L; Kutzner H; Guerra L; Alves do Carmo J; Filipe P; Marques MS
    Am J Dermatopathol; 2014 Oct; 36(10):e167-70. PubMed ID: 23538898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophilic dermatosis after azathioprine exposure.
    Cyrus N; Stavert R; Mason AR; Ko CJ; Choi JN
    JAMA Dermatol; 2013 May; 149(5):592-7. PubMed ID: 23677084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib-induced sweet syndrome in a patient with chronic myeloid leukemia.
    Ayirookuzhi SJ; Ma L; Ramshesh P; Mills G
    Arch Dermatol; 2005 Mar; 141(3):368-70. PubMed ID: 15781678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweet's syndrome without granulocytosis.
    Probert C; Ehmann WC; al-Mondhiry H; Ballard J; Helm KF
    Int J Dermatol; 1998 Feb; 37(2):108-12. PubMed ID: 9542664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sweet's syndrome after splenic irradiation for chronic myelogenous leukemia.
    Pertusi RM; Forman MD; Brown AC
    J Am Osteopath Assoc; 1996 Jun; 96(6):366-7. PubMed ID: 8690626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophilic fixed drug eruption, a histopathologic variant or an expected finding?-A report of two cases and review of the literature.
    Theroux Z; Gardner J; Ortiz E; Kosik G; Junkins-Hopkins J
    J Cutan Pathol; 2023 Oct; 50(10):884-889. PubMed ID: 37403191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib for chronic myelogenous leukemia improves skin symptoms of systemic sclerosis.
    Arai K; Yoshifuji K; Motomura Y; Sonokawa S; Suzuki S; Kumagai T
    Int J Hematol; 2019 Jun; 109(6):718-722. PubMed ID: 30788724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphedema-associated neutrophilic dermatosis: Two cases of localized Sweet syndrome on the lymphedematous lower limbs.
    Chu CH; Cheng YP; Kao HL; Liang CW; Chan JY; Yu Y
    J Dermatol; 2016 Sep; 43(9):1062-6. PubMed ID: 27099208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bortezomib-induced eruption: Sweet syndrome? Two case reports].
    Thuillier D; Lenglet A; Chaby G; Royer R; Vaida I; Viseux V; Dadban A; Billet A; Christophe O; Chatelain D; Marolleau JP; Lok C; Damaj G
    Ann Dermatol Venereol; 2009 May; 136(5):427-30. PubMed ID: 19442799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemetrexed-induced Sweet Syndrome: First case report in the medical literature.
    Korkmaz M; Eryılmaz MK; Karaağaç M; Demirkıran A; Araz M; Artaç M
    J Oncol Pharm Pract; 2021 Jul; 27(5):1307-1310. PubMed ID: 33028131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.